Triomics

New York, New York, USA · ≈87 employees · triomics.com

Triomics is a healthcare technology company focused on generative artificial intelligence for oncology electronic health records (EHRs). Founded in 2020, the company aims to enhance the extraction of critical data from unstructured medical records, streamlining processes for cancer care providers. Triomics is headquartered in New York, NY, and has received significant backing from investors, raising over $28.88 million in funding. The company offers an end-to-end AI platform that integrates into clinical workflows to automate various oncology tasks. Key services include clinical trial matching and enrollment, pre-visit chart preparation, oncology data abstraction, quality improvement reporting, and cancer registry management. Triomics' flagship product, OncoLLM, is designed to interpret complex oncology data and automate data abstraction, while its task-driven AI agents enhance operational efficiency. Triomics serves a diverse clientele, including leading cancer centers, healthcare institutions, pharmaceutical companies, and research organizations, helping them transform unstructured oncology data into actionable insights.